You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NVA

Showing 1 - 25 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial (Glycopyrronium bromide 25ug, Placebo, Glycopyrronium bromide 12.5ug)

Recruiting
  • Asthma
  • Glycopyrronium bromide 25ug
  • +2 more
  • Ruse, Bulgaria
  • +11 more
Jan 23, 2023

Renal Impairment Trial in Moscow (NVA237)

Completed
  • Renal Impairment
  • Moscow, Russian Federation
    Novartis Investigative Site
Dec 16, 2020

Peri-Implantitis Trial in Badajoz (Leatlet + visual aid (pictogram), Leaflet + no visual aid (no pictogram))

Completed
  • Peri-Implantitis
  • Leatlet + visual aid (pictogram)
  • Leaflet + no visual aid (no pictogram)
  • Badajoz, Spain
    Centro de Implantologia Cirugia Oral y Maxilofacial
Sep 9, 2021

OdySight App to Monitor Near Visual Acuity at Home (TIL002)

Completed
  • Visual Impairment
  • Software as medical device
  • Paris, Ile-de-France, France
  • +2 more
Aug 19, 2022

Neovascular Glaucoma Trial in Aurora (Aflibercept)

Completed
Has Results
  • Neovascular Glaucoma
  • Aurora, Colorado
    Rocky Mountain Lions Eye Institute
Feb 16, 2022

COPD Trial in Worldwide (NVA237, Placebo, Salbutamol)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Genk, Limburg, Belgium
  • +80 more
Jun 21, 2019

Tinnitus Trial (Standard Clinical care, Blended physiotherapy program)

Not yet recruiting
  • Tinnitus
  • Standard Clinical care
  • Blended physiotherapy program
  • (no location specified)
Feb 15, 2022

Asthma Trial in Worldwide (NVA237 (glycopyrronium bromide), Placebo)

Completed
Has Results
  • Asthma
  • NVA237 (glycopyrronium bromide)
  • Placebo
  • North Dartmouth, Massachusetts
  • +20 more
Jan 15, 2019

COPD Trial in Germany, Netherlands (Concept2 inhaler, Concept2 inhaler with patient application)

Terminated
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Concept2 inhaler
  • Concept2 inhaler with patient application
  • Berlin, Germany
  • +8 more
Dec 9, 2020

Hearing Loss, Sensorineural, Severe, Hearing Loss, Sensorineural, Bilateral, Hearing Loss, Unilateral Trial in Edegem (Cochlear

Recruiting
  • Hearing Loss, Sensorineural, Severe
  • +4 more
  • Cochlear implant
  • Edegem, Antwerpen, Belgium
    Universitair Ziekenhuis Antwerpen
Jan 4, 2022

Brain Injury, Chronic, Brain Injuries, Traumatic Trial in Bakersfield (Inulin fructooligosaccharide)

Not yet recruiting
  • Brain Injury, Chronic
  • Brain Injuries, Traumatic
  • Inulin fructooligosaccharide
  • Bakersfield, California
    Centre for Neuro Skills
Jun 25, 2021

IOP Decreased, Visual Impairment Trial in Minya (Procedure)

Completed
  • IOP Decreased
  • Visual Impairment
  • Procedure
  • Minya, Egypt
    Minia University
Jan 10, 2020

COPD, COPD Trial in United States (CHF 5259, Placebo, Tiotropium Bromide 18 µg Inhalation Capsule)

Completed
Has Results
  • COPD
  • Chronic Obstructive Pulmonary Disease
  • CHF 5259
  • +2 more
  • Birmingham, Alabama
  • +111 more
May 20, 2021

Glaucoma, Open-Angle, Ocular Hypertension, Eye Diseases Trial in Madrid (Ab interno trabeculectomy, Cataract)

Completed
  • Glaucoma, Open-Angle
  • +5 more
  • Ab interno trabeculectomy
  • Cataract
  • Madrid, Spain
    Hospital San Carlos
Dec 17, 2019

COPD Trial (NVA237, Placebo to NVA237)

Withdrawn
  • Chronic Obstructive Pulmonary Disease
  • (no location specified)
Apr 19, 2017

Near Vision Trial in Paris (Standards vision tests, OdySight medical application assessment)

Completed
  • Near Vision
  • Standards vision tests
  • OdySight medical application assessment
  • Paris, Ile-de-France, France
    Centre Hospitalier National d'Ophtahlomogie du Quinze-Vingts
Jul 26, 2018

Neovascular Glaucoma Trial in Xi'an (Intracameral injection, Intravitreal injection)

Completed
  • Neovascular Glaucoma
  • Intracameral injection
  • Intravitreal injection
  • Xi'an, Shaanxi, China
    Department of Ophthalmology, Second affiliated hospital of Xian
May 21, 2018

COPD Trial in Spartanburg, Albrechtstrasse 14 (Placebo, NVA237)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Spartanburg, South Carolina
  • +1 more
Aug 2, 2016

Pulmonary Disease, Chronic Obstructive Trial (NVA237, Tiotropium Respimat®)

Withdrawn
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
Aug 19, 2016

COPD Trial in Worldwide (Glycopyrronium, SABA, LABA)

Completed
Has Results
  • COPD
  • Amstetten, Austria
  • +543 more
Mar 18, 2019

COPD: COPD Trial in Switzerland (QAB149, Placebo, NVA237)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease: COPD
  • Faltigberg-Wald, ZH, Switzerland
  • +10 more
Jan 11, 2016

COPD (COPD) Trial in United States (NVA237, Long-acting beta 2-agonist (LABA), Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Gulf Shores, Alabama
  • +60 more
Feb 17, 2016

Ischaemic Central Retinal Vein Occlusion, Neovascular Glaucoma Trial (aganirsen)

Unknown status
  • Ischaemic Central Retinal Vein Occlusion
  • Neovascular Glaucoma
  • (no location specified)
Oct 28, 2016

Muscle Strength Quantitative Trait Locus 1 Trial (Physiotherapy Guidance, Physiotherapy Muscle strengthening)

Completed
  • Muscle Strength Quantitative Trait Locus 1
  • Physiotherapy Guidance
  • Physiotherapy Muscle strengthening
  • (no location specified)
Dec 13, 2016

Asthma Trial (NVA237, Placebo to NVA237, salbutamol/ albuterol)

Withdrawn
  • Asthma
  • (no location specified)
Apr 10, 2015